Showing results (261-270 of 410) with videos related to
Sort By:
Pageof 41
Journal of Alzheimer'S Disease : JAD|April 3, 2012
Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease bloodKatie Lunnon, Zina Ibrahim, Petroula Proitsi, et al.Scandinavian Journal of Caring Sciences|October 3, 2025
Integrating Creative Approaches to Dementia Care Into Nursing Programmes: Findings From an International Qualitative StudyCristina Tommasini, Stefanos Mantzoukas, Charlotte Buitenkamp, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Dementia Care Research and Psychosocial FactorsMarianna Tsatali, Athanasia-Lida Dimou, Tarsitsa Ntova, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 29, 2014
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technologyMartina Sattlecker, Steven J Kiddle, Stephen Newhouse, et al.Aging and Disease|August 3, 2021
Extracellular GAPDH Promotes Alzheimer Disease Progression by Enhancing Amyloid-β Aggregation and CytotoxicityVladimir F Lazarev, Magda Tsolaki, Elena R Mikhaylova, et al.Neurobiology of Aging|February 17, 2017
Mitochondrial genes are altered in blood early in Alzheimer's diseaseKatie Lunnon, Aoife Keohane, Ruth Pidsley, et al.Journal of Alzheimer'S Disease : JAD|May 30, 2026
Setting research priorities around the impact of COVID-19 control measures on people with dementia and caregivers living at home: A 14-country perspectiveGeeske Peeters, Rachel L Fitzpatrick, Tatyana Mollayeva, et al.Journal of Alzheimer'S Disease : JAD|October 7, 2017
Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and CognitionBabette L R Reijs, Inez H G B Ramakers, Lyzel Elias-Sonnenschein, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2015
Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?Maria Travassos, Isabel Santana, Inês Baldeiras, et al.The Lancet. Neurology|June 16, 2009
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort studyPieter Jelle Visser, Frans Verhey, Dirk L Knol, et al.Pageof 41